Education
About Us
Working with TipRanks
Follow Us
Bayer (IT:1BAYN)
:1BAYN
1BAYN Stock Chart & Stats
Day’s Range― - ―
52-Week Range€18.31 - €31.00
Previous CloseN/A
Volume47.81K
Average Volume (3M)62.33K
Market Cap
€21.68B
Enterprise Value€66.47B
Total Cash (Recent Filing)€6.19B
Total Debt (Recent Filing)€40.70B
Price to Earnings (P/E)―
Beta0.83
Next Earnings
May 13, 2025EPS Estimate
1.93Next Dividend Ex-Date
Apr 28, 2025Dividend Yield0.48%
Share Statistics
EPS (TTM)-2.60
Shares Outstanding982,424,100
10 Day Avg. Volume41,823
30 Day Avg. Volume62,326
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€26.89Price Target Upside21.73% Upside
Rating ConsensusHold
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Cash Flow And Debt ManagementThe company has implemented measures to maximize cash flow generation, which is crucial given the high level of debt.
Financial PerformanceFY-24 FCF came in at €3.1bn ahead of guidance. Net debt at €32.6bn (FY-23: 34.5bn), which is good news.
Growth ProspectsDespite the bleak outlook for 2025, the medium-term outlook appears much better with potential growth in various segments.
Bears Say
Crop Science PerformanceBayer underperformed significantly due to weaker-than-expected agrochemicals performance and questions on long-term pharma growth.
Generic CompetitionThe generic headwind at Xarelto intensified, leading to forecasted sales losses of €1bn in 2025 and another €800m in 2026.
Litigation UncertaintyOngoing litigation related to glyphosate is creating uncertainty for investors, with 67,000 cases still unsettled.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
12.07%
Mutual Funds
<0.01% Other Institutional Investors
75.57% Public Companies and
Individual Investors
1BAYN FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was €18.31 and its highest was €31.00 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is €21.68B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is May 13, 2025 which is in 41 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Mar 05, 2025. The company reported €1.05 earnings per share for the quarter, beating the consensus estimate of €0.989 by €0.061.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of €0.109 which represents an annual dividend yield of 0.48%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 1.93.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of €1.05 in its last earnings report, beating expectations of €0.989. Following the earnings report the stock price went up 2.394%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in IT:1BAYN
---
Bayer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€26.89 (21.73% Upside)
€26.89 (21.73% Upside)
Insider Transactions
Bought Shares
Worth €150.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.04%
12-Months-Change
Fundamentals
Return on Equity
-7.87%
Trailing 12-Months
Asset Growth
-4.50%
Trailing 12-Months
Company Description
Bayer
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides just over half of the company's sales and includes pharmaceutical drugs as well as vitamins. The company has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
---
1BAYN Stock 12 Month Forecast
Average Price Target
€26.89
▲(21.73% Upside)
Technical Analysis
BASF SE
―
Deutsche Telekom
―
Fresenius Medical Care AG & Co. KGaA
―
Siemens
―
Linde
―
Best Analysts Covering 1BAYN
1 Year
1 Year Success Rate
9/29 ratings generated profit
1 Year Average Return
-12.21%
reiterated a buy rating 7 days ago
Copying Peter Spengler's trades and holding each position for 1 Year would result in 32.14% of your transactions generating a profit, with an average return of -12.21% per trade.
---